SINUS-24/SINUS-52 Demonstrated Reduced Need for Surgery and Oral Corticosteroids — Dupilumab Real-World Data Reinforces with 100% Reduction in the First Year of Treatment in Patients with Severe Uncontrolled CRSwNP

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).² The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.^1,2,3

Læs mere

Lungefunktion ved svær astma – et klinisk perspektiv

Læs mere

Gentagelse af cyklussen: En udfordring hos CRSwNP-patienter

Læs mere

Kronisk rhinosinusitis med næsepolypper: Samspillet mellem type 2-inflammation og lugtesanstab

Læs mere

Kronisk rhinosinusitis med næsepolypper: Mere end blot næsetilstoppelse

Læs mere

Diagnostic Algorithm

Læs mere

Diagnostic and confirmation testing

Gaucher disease is rare and has signs and symptoms that can be confused with those of many other diseases. However, some tests allow the definitive diagnosis of the disease.

Læs mere

Understanding Gaucher Disease: Genetics, Transmission, and Family Screening

Læs mere

Loss of Smell in CRSwNP

Loss of sense of smell is a common symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), but its impact is often underestimated. Learn how olfactory dysfunction affects patient’s quality of life and explore the underlying mechanisms driving smell loss in CRSwNP.

Læs mere